|Follow up complete
|Study Start Date:
|Study Made Public:
A Phase 1 clinical trial to evaluate the safety and immunogenicity of orally-administered replication-competent Adenovirus type-4 HIV vaccine regimens in healthy, HIV-uninfected adult participants
HVTN 110 is a Phase I clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of Ad4-mgag (Ad4), Ad4-EnvC150 (Ad4), and AIDSVAX B/E.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.